Development and validation of new screening tests for nephrotoxic effects

Human and Experimental Toxicology

Volumn 15, Issue SUPPL. 1, 1996, Pages

  Price, R G ^a   Taylor, S A ^a   Chivers, I ^a   Arce Tomas, M ^a   Crutcher, E ^a   Franchini, I ^b   Alinovi, R ^b   Cavazzini, S ^b   Bergamaschi, E ^b   Mutti, A ^b   Vettori, M V ^b   Lauwerys, R ^c   Bernard, A ^c   Kabanda, A ^c   Roels, H ^c   Thielemans, N ^c   Hotz, Ph ^c   De Broe, M E ^d   Elseviers, M M ^d   Nuyts, G D ^d   Gelpi, E ^e   Hotter, G ^e   Rosello, J ^e   Ramis, I ^e   Stolte, H ^f   Fels, L M ^f   Eisenberger, U ^f   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biomarkers; Database; Heavy metals; Nephrotoxicity; Non invasive tests; Solvents

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; HEAVY METAL; LEAD; MERCURY; PROSTAGLANDIN; SOLVENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; EXTRACELLULAR MATRIX; GENDER; HUMAN; INDUSTRIAL WORKER; INTERMETHOD COMPARISON; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SERODIAGNOSIS; SMOKING; URINALYSIS;

BIOLOGICAL MARKERS; DRUG EVALUATION, PRECLINICAL; ENVIRONMENTAL POLLUTANTS; HUMANS; KIDNEY;

EID: 15844382544     PISSN: 01445952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hook JB, Goldstein RS. (ed.) Toxicology of the kidney (2nd Ed.) Raven Press, New York. 1993.
2. Hewitt WR, Goldstern RS, Hook JB. Toxic responses of the kidney. In: The basic science of poisons (Ed.) Amdur MO, Doull J Klassen CD. 4th Edition, Pergamon Press: New York pp 354-382, 1991.
3. Nuyts GD, Elseviers MM, DeBroe ME. Health impact of renal disease due to nephrotoxicity. Toxicol Lett 1989; 46: 31-44.
4. IPCS (International programme on chemical Safety) principles and methods for the assessment of nephrotoxicity associated with exposure to Chemicals. Environmental health criteria 119, Geneva, WHO, 1991, 1-266.
5. Price RG, Urinary enzymes, nephrotoxicity and renal disease. Toxicol 1982; 23: 99-134.
6. Cardenas A, et al. Markers of early renal changes induced by industrial pollutants I. Application to workers exposed to mercury vapour. Brit J Ind Med 1993; 50: 17-27.
7. Cardenas A, et al. Markers of early renal changes induced by industrial pollutants II. Application to workers exposed to lead. Brit J Ind Med 1993; 50: 28-36.
8. Fels LM, et al. Nephron target sites in chronic exposure to lead. Nephrol Dial Transplant 1994; 9: 1740-1746.
9. Roels H, et al. Markers of early renal changes induced by industrial pollutants III. Application to workers exposed to cadmium. Brit J Ind. Med. 1993; 50: 37-48.
10. Fels LM, et al. Early markers of target nephron segments as studied in cadmium toxicity. Kidney Int. 1994; 46 S81-88.
11. Mutti A, et al. Nephropathies and exposure to organic solvents: a survey of dry-cleaners exposed to perchloroethylene. Lancet, 1992; 340: 189-193.
12. Cardenas A, Bernard AM, Lauwerys R. Disturbances of sialic acid metabolism by chronic cadmium exposure and its relation to proteinuria. Toxicol Appl Pharmacol 1991; 108: 547-558.
13. Fish AJ, Kleppel M, Jeraj K, Michael AF. Enzyme immunoassay of anti-glomerular basement membrane antibodies. J Lab Clin Med 1985; 105: 700-705.
14. Bernard AM, Lauwerys R. Continuous flow? system for automation of latex immunoassay by particle counting. Clin Chem 1983; 29: 1007-1011.
15. Macart M, Gerbaut L. Optimization of protein measurement in biological fluids by the dye binding SDS method. Clin Chem 1988; 34: 998-999.
16. Jung K, et al. Urinary proteins and enzymes as indicators of renal dysfunction in chronic exposure to cadmium. Clin Chem 1988; 39: 757-765.
17. Porstmann B, et al. Measurement of lysozyme in human body fluids: Comparison of various enzyme immunoassay techniques and their diagnostic application. Clin Biochem 1989; 22: 349-356.
18. Neuhoff V. Micro-electrophoresis on polyacrylamide gels, In: Micromethods in Molecular Biology, Ed. Neuhoff V, Springer, Berlin, p1, 1973.
19. Mutti A, et al. Urinary excretion of brush border antigen revealed by monoclonal antibodies: early indicator of toxic nephropathy. Lancet 1985; ii: 914-917.
20. Gelpi E, et al. Modern high performance liquid Chromatographic radioimmunoassay strategies for the study of eicosanoids. J Chromatogr Biomed Appl 1989; 492 223-250.
21. Tucker SM, Boyd PJR, Thompson AE, Price RG. Automated assay of N-acetyl-βD-glucosaminidase in normal and pathological human urine. Clin Chim Acta 1975; 62: 333-339.
22. Yuen CT, et al. Colorimetric assay for N-acetyl-β-D-glucosaminidase in pathological urine using nitrostyryl substrate: The development of a kit and comparison of manual procedure with automated fluorometric method. Ann Clin Biochem 1984; 21 295-300.
23. Roels HA, et al. Urinary kallikrein activity in workers exposed to cadmium, lead or mercury vapour. Br J Ind Med 1990; 47: 331-337.
24. Margolius HS, et al. Urinary kallikrein excretion in normal man: relationship to sodium intake and sodium retaining steroids. Cir Res 1974; 35: 812-819.
25. Perkin-Elmer. Clinical methods for atomic absorption spectroscopy. Norwalk, CN: Perkin-Elmer, 1971.
26. Verpooten GF, et al. Segment specific localisation of intestinal type alkaline phosphatase in human kidney. Kid Int 1989; 36: 617-625.
27. Nouwen EJ, De Broe ME. Human intestinal versus tissue non-specific alkaline phosphatase as complementary urinary markers for proximal tubule. Kidney Int 1994; 46: Suppl 47, 43-51.
28. Engval E. Fibronectin. In: Bergmeyer HV (ed): Methods of enzymatic analysis, vol. 1., Verlag Chemie, Weilheim, pp 201-211, 1985.
29. Avrameas S. Coupling enzymes to proteins with glutaraldehyde. Immunochemistry 1969; 6: 43.
30. Whiteman P. The quantitative determination of glycosaminoglycans in urine with Alkane Blue 8GX. Biochem J 1973; 131: 351-357.
31. Price RG, Taylor SA, Crutcher E. Assay of laminin fragments in the assessment of renal disease. Kidney Int 1994; 46: Suppl 47, S25-28.
32. Heinegard B, Tiderstrom G. Determination of serum creatinine by direct colorimetric method. Clin Chim Acta 43: 305-310.
33. Henry RJ. Clinical Chemistry: Principles and Technics, 3rd Ed., Harper and Row, New York, 1965.
34. Magos L, Clarkson T. Atomic absorption determination of total, inorganic and organic mercury in blood. J Assoc of Anal Chem 1973; 55: 966-971.
35. Roels HA, et al. Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium. Br J Ind Med 1991; 48: 365-374.
36. Imbriani M, Chittori S, Pezzagno G, Capodaglio E. Urinary excretion of tetrachloroethylene (perchloroethylene) in experimental and occupational exposure. Arch Environ Health 43: 292-298.
37. Buchet JP, Roels H, Bernard A, Lauwerys RR. Assessment of renal function of workers exposed to inorganic lead, cadmium or mercury vapour. J Occup Med 1980; 22: 741-750.
38. Goyer RA. Mechanism of lead and cadmium nephrotoxicity. Toxicol. Lett. 1989; 46: 153-162.
39. Khalil-Manesh F, et al. Continuous high-dose lead administration. Kid. Int. 1992; 41: 1192-1203.
40. Pergande M, et al. Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplant 1994; 9: 613-618.
41. Verpooten GF, et al. Immunoassay in urine of a specific marker for proximal tubular S3 segment. Clin Chem 1992; 38: 642-647.
42. Patrono C, Dunn MJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int. 1987; 32: 1-12.
43. Hashimoto DM, et al. The presence of urinary sediment and albuminuria in newspaper workers exposed to solvents. J. Occup Med 1991; 33: 516-526.
44. Cardenas AJA. Early renal changes induced by chronic exposure to industrial pollutants. PhD Thesis, Université Catholique de Louvain, 1992.